What is dextromethorphan used for? Dextromethorphan is commonly used to reduce cough caused by common cold or inhaled allergens or that makes it hard for you to fall asleep. Dextromethorphan may also ...

ALLEGAN -- Perrigo Co. (Nasdaq: PRGO) announced that the United States Food and Drug Administration has granted final approval to Tris Pharma for its abbreviated new drug application for ...

Dextromethorphan can cause side effects that range from mild to serious. More common side effects include nausea and drowsiness. If dextromethorphan side effects become difficult to tolerate, talk ...

Dextromethorphan is an over-the-counter (OTC) drug that helps relieve a dry cough from a short-term cause, such as the common cold. Dextromethorphan works in the brain by reducing the urge to cough ...

May 31, 2012Tris Pharma, a technology driven specialty pharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved the first-ever generic to Delsym®, an ...

Aurobindo has obtained the FDA's blessing for generic Ravicti and generic Delsym. The FDA also approved Aurobindo's dextromethorphan polistirex extended-release oral suspension, 30 mg/5 ml (OTC), ...

Perrigo Company and Tris Pharma announced the launch of Dextromethorphan Polistirex Oral Suspension, a store brand equivalent to Reckitt Benckiser‘s Delsym extended–release oral liquid suspension. It ...

Perrigo Company announced that the FDA has granted final approval to Tris Pharma for Dextromethorphan Polistirex extended-release oral suspension, the store-brand equivalent to Reckitt Benckiser‘s ...

ALLEGAN -- Allegan-based Perrigo Co. (Nasdaq: PRGO) and Tris Pharma Inc. announced the commercial launch of a major new store brand product. The new product is equivalent to Delsym extended-release ...

May 30, 2012Perrigo Company (Nasdaq: PRGO;TASE) today announced that the U.S. Food and Drug Administration has granted final approval to Tris Pharma for its abbreviated new drug application (ANDA) for ...

June 24, 2004 — The U.S. Food and Drug Administration (FDA) has approved over-the-counter extended-release guaifenesin/dextromethorphan HBr tablets, an extended ...